Company Profiles

driven by the PitchBook Platform

Myoscience

Myoscience
2005 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$14M LATEST DEAL AMOUNT
8 INVESTORS
Description

Provider of medical technology for cold therapy. The company's proprietary platform technology Focused Cold Therapy is the treatment for conditions involving nerves. Its Iovera system uses precision targeting and the body's natural response to cold for immediate relief without the use of drugs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
46400 Fremont Boulevard
Fremont, CA 94538
United States

+1 (510) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Myoscience’s full profile, request a free trial.

Myoscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 18-Oct-2017 $14M 00000 Completed Profitable
6. Convertible Debt 18-Sep-2014 00.000 00000 Completed Profitable
5. Later Stage VC (Series E1) 12-Sep-2013 0000 000.00 00000 Completed Profitable
4. Later Stage VC (Series D) 21-Mar-2012 0000 000.00 000.00 Completed Profitable
3. Later Stage VC (Series C) 16-Mar-2011 000.00 000.00 000.00 Completed Profitable
2. Early Stage VC (Series B) 13-Oct-2008 $11.4M $14.8M 000.00 Completed Profitable
1. Early Stage VC (Series A) 10-Jan-2007 $3.38M $3.38M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Myoscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 684,874 $0.000100 $1.12 $14 $14 1x $1 6.53%
Series A 422,127 $0.000100 $0.64 $8 $8 1x $0.84 2.75%
To view this company’s complete Cap Table, request access »

Myoscience Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Medicis Capital Venture Capital Minority 000 0000 000000 0
Valiance Growth/Expansion Minority 000 0000 000000 0
Western Technology Investment Venture Capital Minority 000 0000 000000 0
American Equities Overseas Other Minority 000 0000 000000 0
NMT Capital PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Myoscience Executive Team (23)

Name Title Board
Seat
Contact
Info
John Supan Chief Executive Officer & Chief Financial Officer
Tracey Henry General Manager
Eddy Garcia Director, Market Communications
Jeff Creamer Director, Operations
Corydon Hinton Director, Systems Engineering

15 Former Executives

You’re viewing 5 of 23 executives. Get the full list »

Myoscience Board Members (18)

Name Representing Role Since Contact
Info
Anthony Lando Self Board Member 000 0000
Bernard Coulie MD Self Board Member 000 0000
Charles Ruck JD Latham & Watkins Board Member 000 0000
Edwin Snape Ph.D NMT Capital Board Member 000 0000
James Hawkins Self Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 18 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com